filicide
发表于 2025-3-23 12:07:19
https://doi.org/10.1007/978-3-662-57963-3e mammograms and physical exams. The 3 false positives had diagnoses of aprocrine metaplasia and hyperplasia. In axillary tissue, probe counts identified metastatic disease in 3 of 8 patients and verified absence of disease in 10 of 14 patients. False positive counts were obtained in 4 having histop
举止粗野的人
发表于 2025-3-23 16:06:41
Book 1991this volume. The way in which the final assembly of different components of the breast antigens is achieved and their functions are now within our grasp as a result of new understanding of molecular structure of these breast antigens. In addition. newer immunoassays aiming at the earliest detection
hegemony
发表于 2025-3-23 21:23:51
sented in this volume. The way in which the final assembly of different components of the breast antigens is achieved and their functions are now within our grasp as a result of new understanding of molecular structure of these breast antigens. In addition. newer immunoassays aiming at the earliest detection 978-1-4613-6665-2978-1-4615-3740-3
micturition
发表于 2025-3-24 00:11:20
http://reply.papertrans.cn/20/1906/190600/190600_14.png
CRUC
发表于 2025-3-24 05:19:04
http://reply.papertrans.cn/20/1906/190600/190600_15.png
certain
发表于 2025-3-24 08:47:19
http://reply.papertrans.cn/20/1906/190600/190600_16.png
大方一点
发表于 2025-3-24 13:06:18
Molecular Cloning and Expression of Breast Mucin-Associated Antigens000 kDa components. We have used MoAbs gainst the lower molecular weight components to isolate cDNAs that encode the antigens recognized by these MoAbs. We present here the characterization of the cDNAs, the genes that encode them and expression of recombinant HMFG proteins in E. Coli.
Nebulous
发表于 2025-3-24 18:43:44
http://reply.papertrans.cn/20/1906/190600/190600_18.png
isotope
发表于 2025-3-24 20:23:34
http://reply.papertrans.cn/20/1906/190600/190600_19.png
切掉
发表于 2025-3-25 03:11:02
Expression and Prognostic Significance of the HER-2/, Oncogene During the Evolutionary Progression o recommendation by the National Cancer Institute that all patients with node-negative breast cancer should be considered for some form of adjuvant therapy (4). On the other hand, the disease does not recur in the majority (70–80%) of node-negative patients, supporting an alternative point of view th